These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Growth inhibition of B-cell precursor acute lymphoblastic leukemia cell lines by monocytes: a role for prostaglandin E2. Giordano L; Moldwin RL; Downie PA; Goldberg A; Gupta R; Allen R; Aithal NH; Kim DH; Le Moine PJ; Smith SD Leuk Res; 1997 Oct; 21(10):925-32. PubMed ID: 9403003 [TBL] [Abstract][Full Text] [Related]
25. Science Signaling Podcast for 29 November 2016: Pre-B cell receptor signaling in leukemia. Wilson BS; VanHook AM Sci Signal; 2016 Nov; 9(456):c23. PubMed ID: 27899524 [TBL] [Abstract][Full Text] [Related]
26. PRMT5-mediated H4R3sme2 Confers Cell Differentiation in Pediatric B-cell Precursor Acute Lymphoblastic Leukemia. Mei M; Zhang R; Zhou ZW; Ying Z; Wang J; Zhang H; Zheng H; Bao S Clin Cancer Res; 2019 Apr; 25(8):2633-2643. PubMed ID: 30635341 [TBL] [Abstract][Full Text] [Related]
27. Support of BCP-ALL-cells by autologous bone marrow Th-cells involves induction of AID expression but not widespread AID off-target mutagenesis. Traxel S; Lehmann J; Richard S; Sidorov S; Niggli F; Berger C; Nadal D; Bürgler S Cancer Immunol Immunother; 2021 Aug; 70(8):2275-2289. PubMed ID: 33507341 [TBL] [Abstract][Full Text] [Related]
28. Nationwide study of pediatric B-cell precursor acute lymphoblastic leukemia with chromosome 8q24/MYC rearrangement in Japan. Sakaguchi K; Imamura T; Ishimaru S; Imai C; Shimonodan H; Fujita N; Okada K; Taketani T; Kanai R; Tauchi H; Kato M; Kojima Y; Watanabe A; Deguchi T; Hashii Y; Kiyokawa N; Taki T; Saito AM; Horibe K; Manabe A; Sato A; Koh K Pediatr Blood Cancer; 2020 Jul; 67(7):e28341. PubMed ID: 32323914 [TBL] [Abstract][Full Text] [Related]
29. cAMP signalling inhibits p53 acetylation and apoptosis via HDAC and SIRT deacetylases. Kloster MM; Naderi EH; Haaland I; Gjertsen BT; Blomhoff HK; Naderi S Int J Oncol; 2013 May; 42(5):1815-21. PubMed ID: 23483263 [TBL] [Abstract][Full Text] [Related]
30. No significant prognostic value of normal precursor B-cell regeneration in paediatric acute myeloid leukaemia after induction treatment. Bras AE; van den Heuvel-Eibrink MM; van der Sluijs-Gelling AJ; Coenen EA; Wind H; Zwaan CM; te Marvelde JG; van der Burg M; Gibson B; Rijneveld AW; de Haas V; van Dongen JJ; van der Velden VH Br J Haematol; 2013 Jun; 161(6):861-4. PubMed ID: 23577982 [TBL] [Abstract][Full Text] [Related]
31. Survivin and its prognostic significance in pediatric acute B-cell precursor lymphoblastic leukemia. Troeger A; Siepermann M; Escherich G; Meisel R; Willers R; Gudowius S; Moritz T; Laws HJ; Hanenberg H; Goebel U; Janka-Schaub GE; Mahotka C; Dilloo D Haematologica; 2007 Aug; 92(8):1043-50. PubMed ID: 17640858 [TBL] [Abstract][Full Text] [Related]
32. Protumoral role of monocytes in human B-cell precursor acute lymphoblastic leukemia: involvement of the chemokine CXCL10. Lee Y; Chittezhath M; André V; Zhao H; Poidinger M; Biondi A; D'Amico G; Biswas SK Blood; 2012 Jan; 119(1):227-37. PubMed ID: 22058116 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of DNA-PK enhances chemosensitivity of B-cell precursor acute lymphoblastic leukemia cells to doxorubicin. Alikarami F; Safa M; Faranoush M; Hayat P; Kazemi A Biomed Pharmacother; 2017 Oct; 94():1077-1093. PubMed ID: 28821159 [TBL] [Abstract][Full Text] [Related]
34. LNK/SH2B3 regulates IL-7 receptor signaling in normal and malignant B-progenitors. Cheng Y; Chikwava K; Wu C; Zhang H; Bhagat A; Pei D; Choi JK; Tong W J Clin Invest; 2016 Apr; 126(4):1267-81. PubMed ID: 26974155 [TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo anti-leukemic efficacy of cyclic AMP modulating agents against human leukemic B-cell precursors. Myers DE; Chandan-Langlie M; Chelstrom LM; Uckun FM Leuk Lymphoma; 1996 Jul; 22(3-4):259-64. PubMed ID: 8819074 [TBL] [Abstract][Full Text] [Related]
36. Prednisone induces immunophenotypic modulation of CD10 and CD34 in nonapoptotic B-cell precursor acute lymphoblastic leukemia cells. Gaipa G; Basso G; Aliprandi S; Migliavacca M; Vallinoto C; Maglia O; Faini A; Veltroni M; Husak D; Schumich A; Ratei R; Biondi A; Dworzak MN; Cytometry B Clin Cytom; 2008 May; 74(3):150-5. PubMed ID: 18271020 [TBL] [Abstract][Full Text] [Related]
37. Cyclic AMP-Induced p53 Destabilization is Independent of CREB in Pre-B Acute Lymphoblastic Leukemia Cells. Manafi Shabestari R; Safa M; Banan M; Kazemi A Int J Mol Cell Med; 2016; 5(4):220-228. PubMed ID: 28357198 [TBL] [Abstract][Full Text] [Related]
38. Cyclic AMP inhibited proliferation of human aortic vascular smooth muscle cells, accompanied by induction of p53 and p21. Hayashi S; Morishita R; Matsushita H; Nakagami H; Taniyama Y; Nakamura T; Aoki M; Yamamoto K; Higaki J; Ogihara T Hypertension; 2000 Jan; 35(1 Pt 2):237-43. PubMed ID: 10642304 [TBL] [Abstract][Full Text] [Related]
39. Detailed immunophenotyping of B-cell precursors in regenerating bone marrow of acute lymphoblastic leukaemia patients: implications for minimal residual disease detection. Theunissen PMJ; Sedek L; De Haas V; Szczepanski T; Van Der Sluijs A; Mejstrikova E; Nováková M; Kalina T; Lecrevisse Q; Orfao A; Lankester AC; van Dongen JJM; Van Der Velden VHJ; Br J Haematol; 2017 Jul; 178(2):257-266. PubMed ID: 28419441 [TBL] [Abstract][Full Text] [Related]
40. Theophylline-induced B-CLL apoptosis is partly dependent on cyclic AMP production but independent of CD38 expression and endogenous IL-10 production. Mentz F; Merle-Beral H; Dalloul AH Leukemia; 1999 Jan; 13(1):78-84. PubMed ID: 10049064 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]